Nexium®, Prilosec®, and Prevacid® are among a class of drugs called proton pump inhibitors, or PPIs, which relieve heartburn and acid reflux by blocking the enzyme in the wall of the stomach that produces acid. Excessive gastric acid is also responsible for the formation of ulcers in the upper digestive system.
CNN recently reported on a newly published study that concluded that PPI users have a 96% increased risk of developing end-stage kidney failure, and a 28% increased risk of chronic kidney failure compared to people taking other types of heartburn medications. Several other studies back this finding, reporting that long-term PPI use could double or triple the risk of kidney disease.
Reports of kidney damage from PPIs have been documented in the published medical literature since the 1990s. However, the manufacturers of PPIs did not begin warning about potential kidney injury until December 2014, and that warning was limited to Acute Interstitial Nephritis. The current warnings fail to tell patients that irreversible kidney damage may occur before a patient develops symptoms. There are no warnings for Acute Kidney Disease or Chronic Kidney Failure.
Symptoms of kidney disease include: fever, bloody urine, nausea or vomiting, weight gain, and skin rash. People with these symptoms may be experiencing kidney failure and should seek medical treatment immediately.
If you or someone you know suffered acute interstitial nephritis, acute kidney disease/failure, chronic kidney disease/failure, or transplant/dialysis after taking a PPI drug, you should seek immediate legal advice. Click here to inquire about a free consultation at Johnson Johnson & Schaller or call us at 800-783-2434.